Dihydroxyfumaric acid

CAS No. 133-38-0

Dihydroxyfumaric acid( —— )

Catalog No. M32032 CAS No. 133-38-0

Dihydroxyfumaric acid can induce lipid peroxidation in rat liver microsomes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dihydroxyfumaric acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydroxyfumaric acid can induce lipid peroxidation in rat liver microsomes.
  • Description
    Dihydroxyfumaric acid can induce lipid peroxidation in rat liver microsomes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    133-38-0
  • Formula Weight
    148
  • Molecular Formula
    C4H4O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Biochemical and Biophysical Research Communications, 1979,89(4):1239-1244.
molnova catalog
related products
  • Eticlopride hydrochl...

    Eticlopride, an antipsychotic, is a Selective dopamine D2/D3 receptor antagonist (Ki: 0.5/0.16 nM).

  • 1,7-Bis(4-hydroxyphe...

    (4Z,6E)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hepta-4,6-dien-3-one shows growth inhibitory activity in vitro versus bloodstream forms of African trypanosomes, with the IC(50) value in the range of 1-3 microg/mL.

  • Bafrekalant

    Bafrekalant is a diazabicyclo-substituted imidazo[1,2-a]pyrimidine derivative that can be used to study sleep-related breathing disorders such as obstructive and central sleep apnoea and snoring.